CSCI
COSCIENS Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · CA
$2.72
+0.00%Margins
Gross margin
45.6%
EBITDA margin
-172.1%
EBIT margin
-197.7%
Net margin
-199.5%
FCF margin
-192.9%
-265.3%
Return on equity
-68.3%
Return on assets
-199.5%
Return on invested capital
0.32x
Asset turnover
-$17.1M
Cash from operations
$2.94
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2025